A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures
Heather Jim(Moffitt Cancer Center), Luke J. Peppone(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Hyo S. Han(Moffitt Cancer Center), Gary R. Morrow(University of Rochester Medical Center), Margarita Bobonis Babilonia(Moffitt Cancer Center), Julienne E. Bower(APLA Health), Michelle C. Janelsins(University of Rochester), Aasha I. Hoogland(Moffitt Cancer Center), Zeruesenay Desta(Indiana University School of Medicine), Eva Culakova(University of Rochester), Stephen Cole(University of California, Los Angeles), Geoffrey C. Williams(University of South-Eastern Norway)
Cited by 17
Related Papers
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670